Eiko Lifesciences Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 23.1% YoY
Eiko Lifesciences Ltd reported revenue from operations of ₹17.7 Cr (+51.3% YoY) and net profit of ₹1.6 Cr (+23.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +23.1% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Eiko Lifesciences Ltd reported revenue from operations of ₹17.7 Cr (+51.3% YoY) and net profit of ₹1.6 Cr (+23.1% YoY) for Q2 FY27.
Eiko Lifesciences Ltd reported revenue from operations of ₹16.7 Cr (+56.1% YoY) and net profit of ₹1.5 Cr (+36.4% YoY) for Q1 FY27.
Eiko Lifesciences Ltd reported revenue from operations of ₹18.3 Cr (+61.9% YoY) and net profit of ₹1.5 Cr (+25.0% YoY) for Q4 FY26.
Eiko Lifesciences reported standalone annual revenue of ₹44.26 Crore for FY2026. The board also appointed M/s NP Rajput & Co as internal auditors for FY2026-27.